Pfizer Inc. (PFE)
USD 25.89
(-2.04%)
USD 25.89
(-2.04%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 8.7 Billion | 29.26 Billion | 32.58 Billion | 14.4 Billion | 12.58 Billion | 15.82 Billion |
| Net Income | 2.13 Billion | 31.4 Billion | 22.45 Billion | 7.02 Billion | 16.3 Billion | 11.18 Billion |
| Depreciation & Amortization | 6.29 Billion | 5.06 Billion | 5.19 Billion | 4.77 Billion | 6.01 Billion | 6.38 Billion |
| Deferred income taxes | -3.44 Billion | -3.76 Billion | -4.29 Billion | -1.46 Billion | 614 Million | -2.2 Billion |
| Stock-based compensation | 525 Million | 872 Million | 1.18 Billion | 756 Million | 718 Million | 949 Million |
| Change in working capital | -2.17 Billion | -4.45 Billion | 12.8 Billion | -275 Million | -4.03 Billion | -926 Million |
| Other non-cash items | 5.36 Billion | 150 Million | -4.76 Billion | 3.59 Billion | -7.02 Billion | 437 Million |
| Investing Cash Flow | -32.27 Billion | -15.78 Billion | -22.54 Billion | -4.27 Billion | -3.94 Billion | 4.52 Billion |
| Investments in PPE | -3.9 Billion | -3.23 Billion | -2.71 Billion | -2.79 Billion | -2.59 Billion | -2.19 Billion |
| Acquisitions | -43.43 Billion | -22.99 Billion | -12 Million | -621 Million | -10.86 Billion | 154 Million |
| Investment purchases | -31.17 Billion | -38.78 Billion | -47.61 Billion | -14.4 Billion | -7.03 Billion | -13.47 Billion |
| Sales/Maturities of investments | 46.41 Billion | 45.46 Billion | 28.09 Billion | 12.73 Billion | 16.34 Billion | 19.9 Billion |
| Other Investing Activities | -180 Million | 3.76 Billion | -306 Million | 813 Million | 206 Million | 133 Million |
| Financing Cash Flow | 26.06 Billion | -14.83 Billion | -9.81 Billion | -9.64 Billion | -8.48 Billion | -20.44 Billion |
| Debt repayment | -35.94 Billion | -3.29 Billion | -2.1 Billion | -30.32 Billion | -1.86 Billion | -9.62 Billion |
| Dividends payments | -9.24 Billion | -8.98 Billion | -8.72 Billion | -8.44 Billion | -8.04 Billion | -7.97 Billion |
| Common Stock Repurchased | - | -2 Billion | - | - | -8.86 Billion | -12.19 Billion |
| Common Stock Issuance | - | - | - | - | 394 Million | 9.94 Billion |
| Other Financing Activities | 71.25 Billion | -553 Million | 1.01 Billion | 29.12 Billion | 10.28 Billion | -589 Million |
| Accounts receivables | 347 Million | 261 Million | -3.81 Billion | -1.24 Billion | -742 Million | -644 Million |
| Accounts payables | -300 Million | 1.19 Billion | 1.24 Billion | 353 Million | -564 Million | 431 Million |
| Inventory | -1.16 Billion | 592 Million | -1.12 Billion | -736 Million | -1.05 Billion | -717 Million |
| Other working capital | -1.05 Billion | -6.5 Billion | 16.49 Billion | 1.35 Billion | -1.67 Billion | 4 Million |
| Cash at beginning of period | 416 Million | 1.98 Billion | 1.82 Billion | 1.35 Billion | 1.22 Billion | 1.43 Billion |
| Cash at end of period | 2.85 Billion | 468 Million | 1.98 Billion | 1.82 Billion | 1.35 Billion | 1.22 Billion |
| Capital Expenditure | -3.9 Billion | -3.23 Billion | -2.71 Billion | -2.79 Billion | -2.59 Billion | -2.19 Billion |
| Effect of forex changes on cash | -40 Million | -165 Million | -59 Million | -8 Million | -32 Million | -116 Million |
| Net cash flow / Change in cash | 2.43 Billion | -1.51 Billion | 158 Million | 475 Million | 125 Million | -206 Million |
| Free Cash Flow | 4.79 Billion | 26.03 Billion | 29.86 Billion | 11.61 Billion | 9.99 Billion | 13.63 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.5 Billion | 24 Million | 3.12 Billion | 2.13 Billion | -3.34 Billion | -2.39 Billion |
| Depreciation & Amortization | 1.75 Billion | 1.73 Billion | 1.73 Billion | 6.29 Billion | 1.67 Billion | 1.56 Billion |
| Deferred income taxes | -482 Million | -783 Million | -441 Million | -3.44 Billion | -1.85 Billion | -113 Million |
| Stock-based compensation | 274 Million | 206 Million | 220 Million | 525 Million | 121 Million | 151 Million |
| Change in working capital | 6.87 Billion | -3.53 Billion | -3.33 Billion | -2.17 Billion | 8.45 Billion | -1.19 Billion |
| Other non-cash items | -6.2 Billion | 4.24 Billion | 3.48 Billion | 5.36 Billion | 201 Million | 5.45 Billion |
| Investing Cash Flow | -2.05 Billion | 4.6 Billion | 1.73 Billion | -32.27 Billion | -10.99 Billion | 888 Million |
| Investments in PPE | -651 Million | -637 Million | -704 Million | -3.9 Billion | -1.04 Billion | -810 Million |
| Acquisitions | -3.49 Billion | - | 3.49 Billion | -43.43 Billion | -43.4 Billion | -2 Million |
| Investment purchases | -21 Million | 657 Million | -2.01 Billion | -31.17 Billion | -874 Million | -9.2 Billion |
| Sales/Maturities of investments | -1.39 Billion | 4.59 Billion | 4.45 Billion | 46.41 Billion | 34.31 Billion | 10.55 Billion |
| Other Investing Activities | 3.49 Billion | -18 Million | 1 Million | -180 Million | 15 Million | 350 Million |
| Financing Cash Flow | -4.63 Billion | -2.45 Billion | -4.93 Billion | 26.06 Billion | 5.44 Billion | -3.77 Billion |
| Debt repayment | -401 Million | -16 Million | -2.17 Billion | -35.94 Billion | -7.77 Billion | -1.42 Billion |
| Dividends payments | -2.38 Billion | -2.38 Billion | -2.37 Billion | -9.24 Billion | -2.31 Billion | -2.31 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.85 Billion | -63 Million | -386 Million | 71.25 Billion | 15.53 Billion | -37 Million |
| Accounts receivables | - | - | - | 347 Million | 347 Million | - |
| Accounts payables | - | - | - | -300 Million | 822 Million | - |
| Inventory | - | - | - | -1.16 Billion | -1.16 Billion | - |
| Other working capital | 6.87 Billion | -3.53 Billion | -3.33 Billion | -1.05 Billion | 8.45 Billion | -1.19 Billion |
| Cash at beginning of period | 1.05 Billion | 719 Million | 2.85 Billion | 416 Million | 3.14 Billion | 2.63 Billion |
| Cash at end of period | 1.15 Billion | 1.05 Billion | 719 Million | 2.85 Billion | 2.85 Billion | 3.14 Billion |
| Capital Expenditure | -651 Million | -637 Million | -704 Million | -3.9 Billion | -1.04 Billion | -810 Million |
| Effect of forex changes on cash | 9 Million | -18 Million | -28 Million | -40 Million | -1 Million | -32 Million |
| Net cash flow / Change in cash | 100 Million | 333 Million | -2.13 Billion | 2.43 Billion | -295 Million | 516 Million |
| Free Cash Flow | 6.06 Billion | -2.41 Billion | 387 Million | 4.79 Billion | 4.19 Billion | 2.64 Billion |
AUHIF
FAR
SILGO
600346
JACKSON
3K-BAT